Silence Therapeutics Plc Intangible Assets

Silence Therapeutics Plc (SLN) currently reports a intangible assets of $250K as of March 2026. That compares with $310K in the prior-year period — down 20.0% year over year. Use the charts on this page to explore Silence Therapeutics Plc's intangible assets history and peer comparisons.

Silence Therapeutics Plc's intangible assets decreased from $310K to $250K — a 20.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Silence Therapeutics Plc reported $250K in intangible assets as of March 2026. That compares with $310K in the prior-year period — down 20.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $250K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Silence Therapeutics Plc, and consider following SLN for alerts when major investors trade the stock.

Silence Therapeutics Plc is classified in the Healthcare sector. On intangible assets, it currently shows $250K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLN with unrelated industries.